151 related articles for article (PubMed ID: 32620208)
1. [Non-clear cell renal cell carcinoma: clinico-biological characteristics and therapeutic management except surgery].
Thouvenin J; Barthélémy P; Ladoire S
Bull Cancer; 2020 Jun; 107(5S):S56-S65. PubMed ID: 32620208
[TBL] [Abstract][Full Text] [Related]
2. Advanced nccRCC: what therapeutic options in 2022?
Bigot C; Boudier P; Ladoire S; Barthélémy P
Bull Cancer; 2022 May; 109(2S):2S39-2S46. PubMed ID: 35760469
[TBL] [Abstract][Full Text] [Related]
3. Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data.
Barthélémy P; Rioux-Leclercq N; Thibault C; Saldana C; Borchiellini D; Chevreau C; Desmoulins I; Gobert A; Hilgers W; Khalil A; Lemoine N; Schlürmann-Constans F; Négrier S
Cancer Treat Rev; 2021 Jun; 97():102191. PubMed ID: 34015728
[TBL] [Abstract][Full Text] [Related]
4. Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature.
John A; Spain L; Hamid AA
Curr Oncol; 2023 Jan; 30(1):923-937. PubMed ID: 36661719
[TBL] [Abstract][Full Text] [Related]
5. The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature.
Ventriglia J; Passarelli A; Pisano C; Cecere SC; Rossetti S; Feroce F; Forte M; Casartelli C; Tambaro R; Pignata S; Perversi F; Di Napoli M
Crit Rev Oncol Hematol; 2023 Aug; 188():104036. PubMed ID: 37263397
[TBL] [Abstract][Full Text] [Related]
6. Systemic Therapies for the Management of Non-Clear Cell Renal Cell Carcinoma: What Works, What Doesn't, and What the Future Holds.
Zoumpourlis P; Genovese G; Tannir NM; Msaouel P
Clin Genitourin Cancer; 2021 Apr; 19(2):103-116. PubMed ID: 33358151
[TBL] [Abstract][Full Text] [Related]
7. Management of Atypical Renal Cell Carcinomas.
Liaw BC; Mehrazin R; Baker C; Sfakianos JP; Tsao CK
Curr Treat Options Oncol; 2017 Sep; 18(10):61. PubMed ID: 28913767
[TBL] [Abstract][Full Text] [Related]
8. Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview.
Bergmann L; Weber S; Hartmann A; Ahrens M
Expert Rev Anticancer Ther; 2021 Nov; 21(11):1273-1286. PubMed ID: 34291700
[No Abstract] [Full Text] [Related]
9. New molecular targets in non clear renal cell carcinoma: An overview of ongoing clinical trials.
Ciccarese C; Massari F; Santoni M; Heng DY; Sotte V; Brunelli M; Conti A; Cheng L; Lopez-Beltran A; Scarpelli M; Cascinu S; Tortora G; Montironi R
Cancer Treat Rev; 2015 Jul; 41(7):614-22. PubMed ID: 26036356
[TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Inhibition in Advanced Non-Clear Cell Renal Cell Carcinoma: Leveraging Success from Clear Cell Histology into New Opportunities.
Zarrabi K; Walzer E; Zibelman M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359554
[TBL] [Abstract][Full Text] [Related]
11. Non-clear cell renal cell carcinomas: biological insights and therapeutic challenges and opportunities.
Malouf GG; Joseph RW; Shah AY; Tannir NM
Clin Adv Hematol Oncol; 2017 May; 15(5):409-418. PubMed ID: 28591094
[TBL] [Abstract][Full Text] [Related]
12. The Role of Pazopanib in Non-Clear Cell Renal Cell Carcinoma: A Systematic Review.
Sneed GT; Lee S; Brown JN; Hammond JM
Clin Genitourin Cancer; 2019 Dec; 17(6):419-424. PubMed ID: 31585694
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of non-clear cell renal cell carcinoma].
Ohba K; Asai A; Mitsunari K; Matsuo T; Mochizuki Y; Miyata Y; Sakai H
Hinyokika Kiyo; 2015 Feb; 61(2):43-7. PubMed ID: 25812592
[TBL] [Abstract][Full Text] [Related]
14. Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies.
Ciccarese C; Iacovelli R; Brunelli M; Massari F; Bimbatti D; Fantinel E; De Marco V; Porcaro AB; Martignoni G; Artibani W; Tortora G
Eur J Cancer; 2017 Sep; 83():237-246. PubMed ID: 28756136
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
16. Imaging characteristics of papillary renal cell carcinoma by computed tomography scan and magnetic resonance imaging.
Tsuda K; Kinouchi T; Tanikawa G; Yasuhara Y; Yanagawa M; Kakimoto K; Ono Y; Meguro N; Maeda O; Arisawa J; Usami M
Int J Urol; 2005 Sep; 12(9):795-800. PubMed ID: 16201974
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for non-clear-cell renal cell carcinoma.
David KA; Milowsky MI; Nanus DM
Clin Genitourin Cancer; 2006 Mar; 4(4):263-8. PubMed ID: 16729909
[TBL] [Abstract][Full Text] [Related]
18. Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options.
Ahrens M; Scheich S; Hartmann A; Bergmann L;
Oncol Res Treat; 2019; 42(3):128-135. PubMed ID: 30799404
[TBL] [Abstract][Full Text] [Related]
19. [Tumor-to-tumor metastasis in a renal carcinoma: A rare and surprising event].
Chanu T; Pavel CS; Saint-Frison MH; Hescot S; Oro H
Prog Urol; 2015 Oct; 25(12):711-5. PubMed ID: 26341074
[TBL] [Abstract][Full Text] [Related]
20. [Neoadjuvant targeted therapies in renal cell carcinoma].
Bigot P; Pignot G; Bernhard JC; Patard JJ
Prog Urol; 2016 Mar; 26(3):191-6. PubMed ID: 26781767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]